Media

Many more abuse-deterrent formulations are entering the market to help curb the abuse of immediate-release products. But this does not mean these products are safer. The FDA approved Hysingla ER (hydrocodone bitartrate) in 2014. It is an acetaminophen-free, extended-release (ER) opioid for severe pain requiring daily, long-term treatment and for...